Resuming Hepatitis B Vaccine After a Pause

Core Management Principle

The Advisory Committee on Immunization Practices (ACIP) recommends that when any hepatitis B vaccine schedule is interrupted at any point in the series, the series does not need to be restarted, based on immunologic memory 1, 2

The Centers for Disease Control and Prevention (CDC) advises administering the second dose as soon as possible, with a minimum interval of 4 weeks between dose 1 and dose 2, and at least 8 weeks before giving the third dose 1
The third dose must be at least 16 weeks after the first dose 1

The CDC recommends that hemodialysis patients, household or sexual contacts of HBsAg-positive persons, HIV-infected persons, and other immunocompromised individuals resume their delayed series with particular urgency due to ongoing exposure risk 1, 3
Men who have sex with men and current or past persons who inject drugs should also resume their series urgently 2

The ACIP recommends that doses administered ≤4 days before the minimum interval are considered valid and do not need to be repeated 1

The CDC recommends measuring anti-HBs levels 1-2 months after the final dose of the resumed series, with seroprotection defined as anti-HBs ≥10 mIU/mL 3
Testing is recommended for healthcare personnel, hemodialysis patients, HIV-infected persons, and other immunocompromised individuals 1, 3

For healthcare personnel, if anti-HBs remains <10 mIU/mL after one additional dose, complete a second full series (usually 6 doses total), followed by repeat anti-HBs testing 1-2 months after the final dose 1, 3
The CDC recommends performing annual anti-HBs testing and administering booster doses when levels decline to <10 mIU/mL for hemodialysis patients 1, 3

The Centers for Disease Control and Prevention recommends that the third dose of hepatitis B vaccine must be administered at least 16 weeks after the first dose and at least 8 weeks after the second dose, with the final dose not given before 24 weeks of age in infants 4, 5
The minimum interval between dose 1 and dose 2 is 4 weeks, between dose 2 and dose 3 is 8 weeks, and between dose 1 and dose 3 is 16 weeks 4, 5
For infants, the final dose cannot be administered before 24 weeks of age, regardless of when earlier doses were given 4, 5

The Advisory Committee on Immunization Practices establishes a 4-day grace period for vaccine doses administered before the minimum interval, which are considered valid and do not need to be repeated 4, 5

The typical recommended schedule for infants born to HBsAg-negative mothers is birth (or by 2 months), 1-2 months, and 6 months 6, 7
The typical recommended schedule for infants born to HBsAg-positive mothers is birth (within 12 hours with HBIG), 1-2 months, and 6 months 6, 7

If the vaccination series is interrupted, the series should not be restarted, but rather continued where it was left off, with the third dose administered as soon as possible while respecting the minimum intervals 4, 5

The third dose should not be administered before 16 weeks from the first dose, even if 8 weeks have passed since the second dose 4, 5
The final infant dose should not be given before 24 weeks of age, as this may compromise long-term immunity 4, 5
The series should not be restarted if interrupted, but rather continued where it was left off, with inadequate doses or those given too early repeated as necessary 4, 5